Scurr, M. J., Zelek, W. M., Lippiatt, G., Somerville, M., Burnell, S. E. A., Capitani, L., . . . Gallimore, A. (2022). Whole blood‐based measurement of SARS‐CoV‐2‐specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid‐organ cancers. Immunology, 165(2), 250. https://doi.org/10.1111/imm.13433
Chicago Style (17th ed.) CitationScurr, Martin J., et al. "Whole Blood‐based Measurement of SARS‐CoV‐2‐specific T Cells Reveals Asymptomatic Infection and Vaccine Immunogenicity in Healthy Subjects and Patients with Solid‐organ Cancers." Immunology 165, no. 2 (2022): 250. https://doi.org/10.1111/imm.13433.
MLA (9th ed.) CitationScurr, Martin J., et al. "Whole Blood‐based Measurement of SARS‐CoV‐2‐specific T Cells Reveals Asymptomatic Infection and Vaccine Immunogenicity in Healthy Subjects and Patients with Solid‐organ Cancers." Immunology, vol. 165, no. 2, 2022, p. 250, https://doi.org/10.1111/imm.13433.